Unless a tumor shows high susceptibility for viral infection and propagation, the spleen might serve as a main antigen contributor for induction of an anti-viral CD8+ T cell response after systemic application of oncolytic VSV-GP. The gene discussed is CD8A; the disease is neoplasm.